Genetics Quiz
Practice Post Translational Regulation in Genetics with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.
Question 1 / 20
0 of 20 answered
The digestive enzyme pepsin is synthesized as an inactive zymogen, pepsinogen. In the acidic environment of the stomach, pepsinogen undergoes a conformational change that facilitates its autocatalytic cleavage, removing an N-terminal peptide to produce active pepsin. A mutation in pepsinogen prevents this autocatalytic cleavage but does not affect its secretion into the stomach. What is the most likely physiological consequence?
This quiz focuses on Post Translational Regulation, giving you a quick way to practice the rules, question types, and explanations that matter most for Genetics.
Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.
The digestive enzyme pepsin is synthesized as an inactive zymogen, pepsinogen. In the acidic environment of the stomach, pepsinogen undergoes a conformational change that facilitates its autocatalytic cleavage, removing an N-terminal peptide to produce active pepsin. A mutation in pepsinogen prevents this autocatalytic cleavage but does not affect its secretion into the stomach. What is the most likely physiological consequence?
Explanation: Pepsin is a key protease that begins protein digestion in the stomach. If the pepsinogen cannot be converted to its active pepsin form via proteolytic cleavage, protein digestion will not be initiated effectively in the stomach. This will lead to an accumulation of undigested proteins and subsequent malabsorption of their constituent amino acids downstream in the intestines. A is incorrect because trypsin is found in the alkaline environment of the small intestine and activates other zymogens, not pepsinogen. C is incorrect because the mutant protein is inactive, so it cannot damage the stomach lining. D describes a potential compensatory response, but the direct physiological consequence is impaired digestion.
The enzymatic activity of a key metabolic enzyme, ME1, is found to be regulated by reversible acetylation. In its deacetylated state, ME1 is highly active. Experiments show that treatment of cells with Trichostatin A (TSA), a potent inhibitor of histone deacetylases (HDACs), leads to a significant decrease in ME1 activity, while the total amount of ME1 protein remains unchanged. What can be concluded from these results?
Explanation: TSA inhibits HDACs, the enzymes that remove acetyl groups. This inhibition leads to an increase in the acetylation level of their substrates. The experiment shows that under these conditions of increased acetylation, ME1 activity decreases. Since the total protein amount is unchanged, this indicates a post-translational regulatory mechanism. Therefore, ME1 is a substrate for an acetyltransferase (often a non-histone acetyltransferase, but HATs can also act on non-histone proteins), and the addition of an acetyl group to ME1 is an inactivating modification. HDACs normally remove this modification to keep the enzyme active. B is contradicted by the data. C misinterprets the roles of the proteins. D is less likely than direct regulation, as the data perfectly fit a model where ME1 itself is a substrate for reversible acetylation.
The cytotoxic necrotizing factor 1 (CNF1) is a toxin produced by pathogenic E. coli. It functions as an enzyme that targets host cell Rho GTPases (e.g., RhoA, Rac1). CNF1 catalyzes the deamidation of a specific glutamine residue (Gln63 in RhoA) to glutamate within the GTPase's switch II loop. This modification impairs the intrinsic and GAP-stimulated GTP hydrolysis activity of the GTPase. What is the functional consequence of this post-translational modification?
Explanation: Rho GTPases are molecular switches that are 'on' when bound to GTP and 'off' when bound to GDP. The hydrolysis of GTP to GDP, which is accelerated by GTPase-activating proteins (GAPs), is the 'off' switch. The toxin-catalyzed deamidation of glutamine to glutamate in a critical region for hydrolysis effectively breaks this 'off' switch. As a result, the Rho GTPase cannot hydrolyze its bound GTP and becomes locked in the constitutionally active, GTP-bound state. This leads to sustained downstream signaling, such as massive actin cytoskeleton reorganization. A is incorrect as this modification leads to activation, not degradation. B is the opposite of the actual effect. D is incorrect as membrane localization is typically mediated by lipid modifications, not the state of the switch II loop.
During prolonged nutrient starvation, a cell must recycle macromolecules to survive. Which statement most accurately contrasts how the proteasome and autophagy contribute to this process?
Explanation: Starvation is a potent inducer of autophagy, a lysosome-mediated process that engulfs portions of the cytoplasm, long-lived proteins, and entire organelles (like mitochondria) to recycle their components. The ubiquitin-proteasome system (UPS), in contrast, is primarily responsible for the rapid turnover of specific, often short-lived regulatory proteins (e.g., cell cycle regulators, transcription factors). While some components of the UPS may be recycled by autophagy, its primary role in degrading specific substrates continues during starvation. B reverses the primary roles of the two pathways. A is incorrect as autophagy is strongly induced. D is incorrect as the proteasome degrades intracellular, not extracellular, proteins.
The stability of the transcription factor Myc is regulated by phosphorylation. In response to a signal, a specific kinase phosphorylates Myc at Threonine-58. This phosphorylation event creates a recognition site for the E3 ubiquitin ligase FBW7, leading to Myc's ubiquitination and rapid degradation. A mutation T58A (Threonine to Alanine) is a common finding in some cancers. What is the biochemical consequence of this T58A mutation?
Explanation: This scenario describes a 'phospho-degron', where phosphorylation is a prerequisite for degradation. The kinase phosphorylates Threonine-58. The phosphorylated T58 is then recognized by the E3 ligase FBW7, leading to degradation. The T58A mutation substitutes threonine with alanine, an amino acid that cannot be phosphorylated. Without the phosphorylation event at this position, the phospho-degron is not created, FBW7 cannot bind, and Myc is not ubiquitinated. This results in a much more stable Myc protein, which promotes uncontrolled cell proliferation, contributing to cancer. A is incorrect because the mutation's primary effect is on stability, not intrinsic activity. C and D are incorrect descriptions of the mutation's effect.
Iron Regulatory Protein 1 (IRP1) is a bifunctional protein that regulates iron homeostasis. Its function is determined by the presence or absence of a specific post-translational modification. In iron-replete cells, IRP1 acts as a cytosolic aconitase. In iron-depleted cells, it binds to iron-responsive elements (IREs) in mRNAs to regulate their translation. What modification mediates this switch in IRP1 activity?
Explanation: The switch in IRP1 function is directly controlled by the presence of a [4Fe-4S] iron-sulfur cluster. When cellular iron levels are high, this cluster is assembled within the protein, which confers aconitase activity and simultaneously prevents the protein from binding to RNA. When iron levels are low, the cluster disassembles, causing a conformational change that unmasks the RNA-binding site, allowing IRP1 to bind to IREs and regulate translation. This is a direct sensing mechanism where the cofactor (the iron-sulfur cluster) itself is the post-translational modification that dictates protein function. The other options describe common PTMs but are not the mechanism used by IRP1.
Cystic fibrosis is often caused by the ΔF508 mutation in the CFTR protein, which leads to a minor misfolding of the protein. Although the mutant protein would be partially functional if it reached the plasma membrane, over 99% of it is retained in the ER and degraded. Low-dose treatment with a proteasome inhibitor can partially restore CFTR function in cultured cells with this mutation. What does this observation imply about the fate of the ΔF508 CFTR protein?
Explanation: The ΔF508 mutation causes a folding defect that is detected by the stringent ER quality control (ERQC) machinery. Chaperones recognize the misfolded protein and target it for the ER-associated degradation (ERAD) pathway. This involves retro-translocation to the cytoplasm, ubiquitination, and degradation by the proteasome. The fact that a proteasome inhibitor restores some function indicates that the degradation is proteasome-dependent and that by slowing this degradation, some protein can escape the ERQC, traffic to the membrane, and function. A is incorrect because ΔF508 is a deletion, not a nonsense mutation. C is incorrect as the primary defect is ER retention. D is incorrect because ERAD uses the proteasome, not the lysosome, for degradation of single misfolded proteins.
Proinsulin is processed into active insulin through proteolytic cleavage that removes an internal C-peptide. A mutation occurs in the proinsulin gene that alters the amino acid sequence at one of the proteolytic cleavage sites, rendering it unrecognizable to the required prohormone convertase enzymes in the Golgi. What is the most likely fate of this mutant proinsulin molecule?
Explanation: The mutation affects a cleavage site, not the signals for folding or trafficking. Therefore, the proinsulin molecule would likely fold correctly in the ER, traverse the Golgi, and be packaged into secretory vesicles along with normal proinsulin. The proteolytic processing by prohormone convertases occurs within these maturing secretory vesicles. Since the cleavage site is mutated, this specific processing step will fail. The cell would then secrete the unprocessed proinsulin upon receiving the appropriate signal (e.g., high blood glucose). This is the basis of some forms of familial hyperproinsulinemia. B is incorrect because a cleavage site mutation does not necessarily cause misfolding. D is incorrect because the sorting signals for regulated secretion are distinct from the cleavage sites.
A patient presents with a severe neurodegenerative disease characterized by the toxic accumulation of a specific cytosolic protein, Protein A. Genetic sequencing reveals that the gene for Protein A is wild-type. However, a homozygous loss-of-function mutation is found in another gene. Which of the following genes is most likely to be the site of this mutation?
Explanation: The specificity of the ubiquitin-proteasome system lies with the E3 ubiquitin ligases, which are responsible for recognizing specific substrates (like Protein A) and catalyzing the transfer of ubiquitin to them. A loss-of-function mutation in the specific E3 ligase for Protein A would prevent its ubiquitination and subsequent degradation, leading to its accumulation without affecting the degradation of other proteins. Mutations in an E1 enzyme (B) or a general proteasome subunit (A) would cause a global defect in protein degradation, which would likely be embryonic lethal or result in a much more complex, multi-system phenotype than the accumulation of a single protein. A mutation in a chaperone (D) could lead to misfolding and aggregation, but the most direct cause for failed degradation of a specific protein is the loss of its specific E3 ligase.
The drug bortezomib is a proteasome inhibitor used in cancer therapy. It is particularly effective against multiple myeloma, a cancer of plasma cells that synthesize large quantities of antibodies. While multiple mechanisms are at play, a primary reason for its efficacy is the induction of apoptosis in these cancer cells. How does proteasome inhibition lead to this outcome?
Explanation: The ubiquitin-proteasome system is responsible for degrading many short-lived regulatory proteins, including pro-apoptotic factors like p53 and certain BH3-only proteins that are normally kept at low levels. By inhibiting the proteasome, bortezomib causes these proteins to accumulate, which crosses the threshold required to initiate the apoptotic cascade. B is incorrect because proteasome inhibitors block degradation, not synthesis. C is incorrect as misfolded proteins in the secretory pathway trigger the unfolded protein response (UPR) in the ER, not direct caspase activation in the cytoplasm. D is incorrect because while cell cycle effects occur, the key apoptotic trigger is the stabilization of pro-apoptotic factors.
The tumor suppressor protein p53 can be modified at lysine residue 320 (K320) by either ubiquitination, which targets it for degradation, or by SUMOylation. These two modifications are mutually exclusive at this site. Overexpression of the SUMO E3 ligase PIASy is observed in a particular cancer cell line. Assuming p53 is wild-type, what is the expected effect of PIASy overexpression on p53 function?
Explanation: SUMOylation and ubiquitination often compete for the same lysine residues. In the case of p53, ubiquitination at K320 promotes its degradation. If the SUMO E3 ligase PIASy is overexpressed, it will increase the rate of SUMOylation at K320. This modification will physically block the same site from being ubiquitinated. By preventing ubiquitination, SUMOylation leads to the stabilization and accumulation of p53 protein, which would be expected to enhance its tumor suppressor functions (e.g., cell cycle arrest, apoptosis). A is incorrect because SUMOylation here is protective against degradation, thus increasing stability. C is incorrect as neither modification targets p53 to the lysosome. D is incorrect as the level of E3 ligases can shift the balance between competing modifications.
A point mutation in the gene for Cyclin B results in the substitution of a key lysine residue within its destruction box (D-box) to an arginine. This mutant Cyclin B retains its ability to form a complex with Cdk1 and activate it. Which of the following is the most likely consequence of this mutation on the cell cycle?
Explanation: The destruction box (D-box) is recognized by the E3 ubiquitin ligase APC/C, which polyubiquitinates Cyclin B at specific lysine residues to target it for proteasomal degradation. This degradation is required for mitotic exit. A lysine-to-arginine mutation prevents ubiquitination. Therefore, Cyclin B will not be degraded, the Cyclin B/Cdk1 complex will remain active, and the cell will be arrested in metaphase, unable to proceed to anaphase. A is incorrect because the mutation stabilizes, not destabilizes, Cyclin B. B is incorrect as the stem states the complex can be activated. D is incorrect because stable Cyclin B prevents, rather than accelerates, mitotic exit.
Polyubiquitin chains can be linked via different lysine residues on ubiquitin, leading to different cellular outcomes. An experiment is designed using a cell line that exclusively expresses a mutant form of ubiquitin where lysine 48 is replaced by arginine (K48R). Which cellular process would be most severely impaired in this cell line?
Explanation: K48-linked polyubiquitin chains are the canonical signal for targeting proteins to the 26S proteasome for degradation. The K48R mutation prevents the formation of these chains. ER-associated degradation (ERAD) of misfolded proteins relies on K48-linked polyubiquitination to direct them to the proteasome. Therefore, this process would be severely impaired. B and D are incorrect because NF-κB signaling and DNA damage response are primarily mediated by K63-linked polyubiquitin chains, which would be unaffected. C is incorrect because receptor endocytosis is often signaled by monoubiquitination or short ubiquitin chains, not necessarily K48-linked chains.
An allosteric enzyme is regulated by phosphorylation of a serine residue located in its regulatory domain, which is distant from the catalytic active site. Kinetic analysis reveals that phosphorylation increases the enzyme's Vmax by a factor of 10 but has no effect on the Km for its substrate. Which statement provides the best explanation for this observation?
Explanation: This is a classic example of allosteric regulation. The phosphorylation event in the regulatory domain induces a long-range conformational change that is transmitted to the active site. This change enhances the enzyme's ability to convert bound substrate into product (turnover rate, or kcat), which is reflected by an increase in Vmax. Since the Km (a measure of substrate binding affinity) is unchanged, the modification does not affect how well the substrate binds, only how quickly it is processed once bound. B is incorrect because the phosphorylation site is distant from the active site. C is incorrect because release of competitive inhibition would decrease Km. D is incorrect as it describes a situation where Km would decrease, which contradicts the data.
A 95 kDa precursor protein is observed to undergo a reaction in vitro without the addition of any other enzymes. The reaction products are a mature, functional 55 kDa protein and a free 40 kDa protein fragment. This process is found to be a key step in the protein's maturation. Which post-translational mechanism does this describe?
Explanation: The scenario describes a precursor protein that self-catalytically removes an internal segment. The internal, excised segment is called an intein (the 40 kDa fragment), and the flanking segments that are ligated together are called exteins (forming the 55 kDa mature protein). This process, known as protein splicing, is autocatalytic and does not require external enzymes or energy cofactors, matching the description. Zymogen activation (A) requires an external protease. Proteasomal degradation (B) would cleave the protein into very small peptides, not discrete large fragments. Autophagy (D) is a mechanism for degradation, not for producing a specific mature protein product.
Recombinant antibodies for therapeutic use are often produced in mammalian cell lines (e.g., CHO cells) rather than bacterial systems (e.g., E. coli), despite the higher cost and lower yield. This is because a critical post-translational modification necessary for the proper folding and assembly of antibody heavy and light chains is absent in bacteria. Which modification is this?
Explanation: Antibodies are composed of heavy and light chains that are stabilized by numerous intramolecular and intermolecular disulfide bonds. These covalent bonds are essential for the correct tertiary and quaternary structure (and thus function) of the antibody. Disulfide bond formation is an oxidative process that occurs in the lumen of the endoplasmic reticulum in eukaryotes. The cytoplasm of E. coli is a reducing environment, which prevents the efficient and correct formation of these critical bonds, leading to misfolding and aggregation of the recombinant proteins. While glycosylation (B) is also important for antibody function and is absent in bacteria, the formation of disulfide bonds is more fundamental to its basic structural integrity.
The drug bortezomib is a proteasome inhibitor used in cancer therapy. It is particularly effective against multiple myeloma, a cancer of plasma cells that synthesize large quantities of antibodies. While multiple mechanisms are at play, a primary reason for its efficacy is the induction of apoptosis in these cancer cells. How does proteasome inhibition lead to this outcome?
Explanation: The ubiquitin-proteasome system is responsible for degrading many short-lived regulatory proteins, including pro-apoptotic factors like p53 and certain BH3-only proteins that are normally kept at low levels. By inhibiting the proteasome, bortezomib causes these proteins to accumulate, which crosses the threshold required to initiate the apoptotic cascade. B is incorrect because proteasome inhibitors block degradation, not synthesis. C is incorrect as misfolded proteins in the secretory pathway trigger the unfolded protein response (UPR) in the ER, not direct caspase activation in the cytoplasm. D is incorrect because while cell cycle effects occur, the key apoptotic trigger is the stabilization of pro-apoptotic factors.
The digestive enzyme pepsin is synthesized as an inactive zymogen, pepsinogen. In the acidic environment of the stomach, pepsinogen undergoes a conformational change that facilitates its autocatalytic cleavage, removing an N-terminal peptide to produce active pepsin. A mutation in pepsinogen prevents this autocatalytic cleavage but does not affect its secretion into the stomach. What is the most likely physiological consequence?
Explanation: Pepsin is a key protease that begins protein digestion in the stomach. If the pepsinogen cannot be converted to its active pepsin form via proteolytic cleavage, protein digestion will not be initiated effectively in the stomach. This will lead to an accumulation of undigested proteins and subsequent malabsorption of their constituent amino acids downstream in the intestines. A is incorrect because trypsin is found in the alkaline environment of the small intestine and activates other zymogens, not pepsinogen. C is incorrect because the mutant protein is inactive, so it cannot damage the stomach lining. D describes a potential compensatory response, but the direct physiological consequence is impaired digestion.
A patient presents with a severe neurodegenerative disease characterized by the toxic accumulation of a specific cytosolic protein, Protein A. Genetic sequencing reveals that the gene for Protein A is wild-type. However, a homozygous loss-of-function mutation is found in another gene. Which of the following genes is most likely to be the site of this mutation?
Explanation: The specificity of the ubiquitin-proteasome system lies with the E3 ubiquitin ligases, which are responsible for recognizing specific substrates (like Protein A) and catalyzing the transfer of ubiquitin to them. A loss-of-function mutation in the specific E3 ligase for Protein A would prevent its ubiquitination and subsequent degradation, leading to its accumulation without affecting the degradation of other proteins. Mutations in an E1 enzyme (B) or a general proteasome subunit (A) would cause a global defect in protein degradation, which would likely be embryonic lethal or result in a much more complex, multi-system phenotype than the accumulation of a single protein. A mutation in a chaperone (D) could lead to misfolding and aggregation, but the most direct cause for failed degradation of a specific protein is the loss of its specific E3 ligase.
The stability of the transcription factor Myc is regulated by phosphorylation. In response to a signal, a specific kinase phosphorylates Myc at Threonine-58. This phosphorylation event creates a recognition site for the E3 ubiquitin ligase FBW7, leading to Myc's ubiquitination and rapid degradation. A mutation T58A (Threonine to Alanine) is a common finding in some cancers. What is the biochemical consequence of this T58A mutation?
Explanation: This scenario describes a 'phospho-degron', where phosphorylation is a prerequisite for degradation. The kinase phosphorylates Threonine-58. The phosphorylated T58 is then recognized by the E3 ligase FBW7, leading to degradation. The T58A mutation substitutes threonine with alanine, an amino acid that cannot be phosphorylated. Without the phosphorylation event at this position, the phospho-degron is not created, FBW7 cannot bind, and Myc is not ubiquitinated. This results in a much more stable Myc protein, which promotes uncontrolled cell proliferation, contributing to cancer. A is incorrect because the mutation's primary effect is on stability, not intrinsic activity. C and D are incorrect descriptions of the mutation's effect.